A preclinical study led by the Germans Trias i Pujol Research Institute (IGTP), in collaboration with the Institut de Myologie and the Sant Pau Research Institute, has analysed the role of the protein...
Read more
Oryzon Genomics announced today that the first patient has been dosed in an investigator-initiated Phase Ib dose-finding trial evaluating iadademstat, Oryzon’s potent and selective LSD1 inhibitor, i...
Read more
An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group, and published in Nature Genetics, has solved a key qu...
Read more
A study coordinated by the Institut de Neurociències of the Universitat Autònoma de Barcelona proposes a new treatment for glioblastoma, the most aggressive brain tumor. The approach involves patche...
Read more
Children and adolescents affected by juvenile fibromyalgia show greater sensitivity to non-painful sensory stimuli, such as sounds and bright lights. This hypersensitivity is closely related to the se...
Read more
The ACE2-Fc protein shows a strong ability to block the most evolved variants of the virus and maintains its effectiveness against mutations that have reduced the impact of other antibodies
Read more
El equipo investigador, del grupo de investigación en Nutrigenómica de la URV, busca personas voluntarias con presión arterial ligeramente elevada para participar en el estudio, impulsado conjuntam...
Read more
El hallazgo, conseguido en el estudio CORDIOPREV, mejora la identificación de personas en riesgo y refuerza la prevención personalizada mediante dieta mediterránea.
Read more
La compañía biomédica Aortyx ha sido distinguida con el Premio Catalonia.health 2026 durante la 12.ª edición de La Nit, el encuentro anual de referencia del sector de la salud y las ciencias de l...
Read more
GENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).
Read more
Viva In Vitro Diagnostics, compañía biomédica española especializada en medicina inmunológica y en el desarrollo de soluciones innovadoras basadas en el inflamasoma NLRP3, ha incorporado al Prof....
Read more
A multidisciplinary Clínic-IDIBAPS team, part of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has published phase 2 results of the CAR-T ARI-0001 (varnimcabtagene autoleucel) for treating...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Many repetitive regions of the genome have been considered “junk DNA...
